Sumary Decreased expression of E-cadherin (E-CD). a homotypic intercellular adhesion molecule, is considered to elicit detachment of tumour cells from primary lesions, which is the first stage of metastasis. Since renal cell cancer (RCC) shows a relatively high frequency of metastasis, we focused our interest on E-CD expression in RCC and its clinicopathological implications. We examined E-CD expression in normnal kidney and RCC by immunohistochemical staining. In normal kidney, E-CD expression was localised in distal tubules and collecting ducts. In RCC, 20 of 106 primary lesions (18.9%) expressed E-CD. whereas none showed positive staining for eight metastatic lesions. There was a statistically significant correlation between loss of E-CD expression and advanced stages of RCC. Kaplan-Meier analysis showed better prognosis in the group with preserved E-CD expression than without E-CD expression (Cox -Mantel test. P = 0.022, the average follow-up was 32 months or until death). This study suggests that the patients with decreased E-CD expression may be associated with metastasis, resulting in poor prognosis. However, frequency of E-CD expression in RCC is lower than in other cancers, which may be derived from the localised distribution of E-CD expression in normal kidney.
It is well known that cadherins, a family of Ca2+-dependent intercellular adhesion molecules, play essential roles in organogenesis and in the maintenance of normal structure and function (Behrens et al., 1985; Eidelman et al., 1989; Takeichi, 1991) . Recently, E-cadherin (E-CD), a subclass of cadherins, has come to be considered to be important as an inhibitory factor in metastasis (Behrens et al., 1985; Frixen et al., 1991; Takeichi, 1991) . The first stage of metastasis is detachment of tumour cells from the primary lesion, which is induced by an alteration of intercellular adhesion. Behrens et al. (1985) demonstrated that Madin-Darby canine kidney epithelial cells have invasive properties when intercellular adhesion is inhibited by anti-E-CD antibodies. In a report on various human cell lines, Frixen et al. (1991) showed that loss of E-CD can generate an invasive phenotype, which can be prevented by transfection with E-CD cDNA. Clinically, the correlation between decreased E-CD expression and advanced stages or dedifferentiation was also reported in a variety of tumours (Frixen et al., 1991; Shiozaki et al., 1991; Oka et al., 1992; Umbas et al., 1992; Bringuier et al., 1993; Oka et al., 1993; Terpe et al., 1993) . However, reports in relation to the prognosis of malignant tumours have been rare until now (Bringuier et al., 1993 Immunohistochemical staining Anti-E-CD monoclonal antibody (HECD-1, Takara Biomedicals, Tokyo, Japan) was used in this study, and immunoperoxidase staining was performed by modifying the streptavidin-biotin bridge technique described previously (Katagiri et al., 1993 in TBS+ with three changes of the buffer. The sections were immersed in 0.05% diaminobenzidine (Sigma, St Louis, MO, USA) and 0.01% hydrogen peroxide in 0.05 mol 1-1 Tris HCI buffer for 3-5 min to visualise the reaction products. After washing in tap water, the specimens were counterstained with Mayer's haematoxylin and mounted with Eukitt (O. Kulder, Freiburg, Germany) after dehydration in a graded ethanol series and xylene. We evaluated E-CD expression in RCCs using normal renal tissues as a positive control. As a negative control, the monoclonal antibody, HECD-1, was replaed by anti-Leul2 (Becton Dickinson, Mountain View, CA, USA), a mouse monoclonal antibody of the same subclass (IgGI).
Evaluation of the staining When reacted with HECD-1, most of tumours showed membranous staining except for one case which showed cytoplasmic staining with membranous expression and was evaluated as positive. In this study, almost all of reacted specimens showed diffuse staining pattern in tumours. Although a range of staining intensity was observed in this study, specimens with diffuse and definite staining as compared with the negative control were designated as positive.
Results E-CD expression in normal kidney and RCC Normal distal tubules and collecting ducts showed a uniform expression of E-CD mainly on their cell surfaces, whereas E-CD expression on proximal tubules was scattered and doubtful ( Figure 1) node and subcutaneous skin tissue expressed E-CD. In cases where specimens of primary and metastatic lesions were obtained, E-CD expression was lost at both sites (Table II and Figure 1 ).
Correlation between E-CD expression and clinicopathological features Absence of E-CD expression was correlated with the advanced stages (stage 3 or 4, P<0.01 in chi-square test, Table I ). All grade 3 tumours and most grade 2 tumours lost E-CD expression (not significant in chi-square test, Table I ). There was no difference in adjuvant therapy among the groups.
Correlation between E-CD expression and prognosis Kaplan-Meier actual statistics were used to evaluate the relationship between E-CD expression and disease outcome. Figure 2 is the Kaplan-Meier curve comparing survival of patients based on E-CD expression, and demonstrates a statistically significnt difference between the group with E-CD expression and the group without E-CD expression (P = 0.022 in Cox-Mantel test). An apparent difference in diseasefree survival fell short of statistical significance (P = 0.078 in Cox-Mantel test, Figure 3 ). Only 1 of 20 patients with preserved E-CD expression had metastasis within 14 months, dying within 44 months after nephrectomy.
In this study, we examined the expression of E-CD in normal kidney and RCC. In previous studies by Eidelman et al.
Fugwe 1 E-CD expression in normal kiey and RCC. In normal kidny (a) In recent years. it has become apparent that cadhenn functions as a complex called adherens junction that includes several other proteins such as catenins and links to actin filaments (Takeichi, 1991) . Hirano et al. (1992) demonstrated that transfection of x-catenin cDNA to cells which do not show the homotypic adhesion, in spite of preserved E-CD expression. can bring about aggregation and the arrangement of the cells. It has also been found that tyrosine phosphorylation of cadherin and catenins inhibits the cadherin-associated functions (Behrens et al.. 1993) . which suggests the possibility of transient modification of the intercellular adhesion.
In conclusion, we demonstrated the clinical value of E-CD expression in RCC as a good prognostic factor. Examination of E-CD in RCC might be beneficial to the evaluation of the metastatic potential of RCC cells resulting in the patient's prognosis. However, as mentioned above. other important molecules or factors which play with E-CD in cell to cell adhesion. including A-CAM, catenins and tyrosine phosphorylation of adherens junction, should be taken into account.
